SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
종목 코드 SIBN
회사 이름SI-BONE Inc
상장일Oct 17, 2018
CEOMs. Laura A. Francis
직원 수349
유형Ordinary Share
회계 연도 종료Oct 17
주소471 El Camino Real, Suite 101
도시SANTA CLARA
증권 거래소Moscow Interbank Currency Exchange (MICEX)
국가United States of America
우편 번호95050
전화14082070700
웹사이트https://si-bone.com/
종목 코드 SIBN
상장일Oct 17, 2018
CEOMs. Laura A. Francis
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음